首页> 外文OA文献 >High-dose Chemotherapy with Stem Cell Rescue Provided Durable Remission for Classical Hodgkin Lymphoma-type Post-transplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature
【2h】

High-dose Chemotherapy with Stem Cell Rescue Provided Durable Remission for Classical Hodgkin Lymphoma-type Post-transplant Lymphoproliferative Disorder after Unrelated Cord Blood Transplantation: A Case Report and Review of the Literature

机译:干细胞挽救的高剂量化疗为经典霍奇金淋巴瘤移植后淋巴细胞增殖性疾病的无关脐带血移植提供了持久的缓解:病例报告和文献综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An adult woman developed polymorphic post-transplant lymphoproliferative disorder (PTLD) 58 months after unrelated cord blood transplantation. She was treated successfully with chemotherapy and radiation therapy but presented with lymphadenopathy and splenomegaly 74 months after transplantation. A lymph node biopsy confirmed the diagnosis of nodular sclerosis type Hodgkin lymphoma (classical Hodgkin lymphoma [CHL]-type PTLD). After salvage therapy and hematopoietic stem cell harvesting, she was subsequently treated with consolidative high-dose chemotherapy with melphalan followed by stem cell rescue, which resulted in durable remission. High-dose chemotherapy using stem cell rescue has potential as a therapeutic option for subsequent CHL-type PTLD.
机译:一名成年女性在无关的脐血移植后58个月出现了多态性移植后淋巴组织增生性疾病(PTLD)。她通过化学疗法和放射疗法成功治疗,但在移植后74个月出现淋巴结肿大和脾肿大。淋巴结活检证实了结节性硬化型霍奇金淋巴瘤(经典霍奇金淋巴瘤[CHL]型PTLD)的诊断。抢救治疗和造血干细胞收获后,她随后接受了美法仑合并大剂量联合化疗,随后进行了干细胞抢救,从而获得了持久的缓解。使用干细胞抢救的大剂量化疗有潜力作为后续CHL型PTLD的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号